An exploratory study to evaluate the efficacy, safety, particularly renal function, and tolerability of three regimes of immunosuppressive therapy, in patients who have undergone liver transplantation

Trial Profile

An exploratory study to evaluate the efficacy, safety, particularly renal function, and tolerability of three regimes of immunosuppressive therapy, in patients who have undergone liver transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2010

At a glance

  • Drugs Corticosteroids; Daclizumab; Mycophenolate mofetil; Mycophenolate mofetil; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Adverse reactions
  • Acronyms Elite-ReSpECT; ReSpECT
  • Sponsors Roche
  • Most Recent Events

    • 23 Feb 2010 Additional trial location (Austria) added as reported by Roche record.
    • 09 Jan 2008 Status changed from in progress to completed.
    • 01 Oct 2007 Six- and 12-month data presented at ESOT 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top